INDV
NASDAQ · Pharmaceuticals
Indivior Pharmaceuticals Inc
$28.79
-0.60 (-2.04%)
Performance
1D
—
1W
—
1M
—
3M
-20.49%
6M
+20.36%
1Y
+200.52%
YTD
-19.42%
Open$29.15
Previous Close$29.39
Day High$29.24
Day Low$27.68
52W High$38.00
52W Low$8.64
Volume—
Avg Volume2.07M
Market Cap4.01B
P/E Ratio32.07
EPS$0.98
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$34.90
Below
SMA 200
$24.61
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
13 analysts
Price Target
+68.5% upside
Current
$28.79
$28.79
Target
$48.50
$48.50
$40.68
$48.50 avg
$71.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.11B | 968.83M | 1.33B |
| Net Income | 2.81M | 2.21M | 235.99M |
| Profit Margin | 0.3% | 0.2% | 17.8% |
| EBITDA | 24.28M | 20.14M | 342.24M |
| Free Cash Flow | — | — | 277.67M |
| Rev Growth | +14.5% | +14.5% | +22.2% |
| Debt/Equity | 5.43 | 5.43 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |